BIOMARIN PHARMACEUTICAL INC (BMRN) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Biomarin Pharmaceutical Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$533 M, a 27.8% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$533 M +$205 M +27.8% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 -$622 M +$168 M +21.2% Dec 31, 2023 10-Q 2024-04-26
Q3 2023 -$642 M +$147 M +18.6% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$682 M +$94.9 M +12.2% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$738 M +$66.5 M +8.27% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 -$789 M +$142 M +15.2% Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$789 M +$78.8 M +9.09% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 -$777 M +$54.1 M +6.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$805 M +$39.3 M +4.66% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 -$931 M -$69.2 M -8.03% Dec 31, 2021 10-K 2023-02-27
Q3 2021 -$868 M +$15.9 M +1.8% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 -$831 M +$837 M +50.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 -$844 M +$795 M +48.5% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 -$862 M +$859 M +49.9% Dec 31, 2020 10-K 2022-02-25
Q3 2020 -$884 M +$852 M +49.1% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 -$1.67 B +$122 M +6.83% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$1.64 B +$114 M +6.5% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 -$1.72 B -$26.6 M -1.57% Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$1.74 B -$45.3 M -2.68% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 -$1.79 B -$113 M -6.73% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 -$1.75 B -$92.3 M -5.56% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 -$1.69 B -$56.6 M -3.46% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$1.69 B -$104 M -6.58% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 -$1.68 B -$104 M -6.62% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 -$1.66 B -$124 M -8.09% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 -$1.64 B -$117 M -7.7% Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$1.59 B -$13.1 M -0.83% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 -$1.57 B -$43.4 M -2.83% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 -$1.54 B -$430 M -38.9% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 -$1.52 B -$499 M -48.8% Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$1.57 B -$483 M -44.3% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 -$1.53 B -$531 M -53.1% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 -$1.11 B -$189 M -20.7% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 -$1.02 B -$172 M -20.2% Dec 31, 2015 10-K 2017-02-27
Q3 2015 -$1.09 B -$310 M -39.8% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 -$999 M -$212 M -26.9% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 -$917 M -$163 M -21.7% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 -$850 M -$134 M -18.7% Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$780 M -$126 M -19.3% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 -$787 M -$187 M -31.1% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 -$754 M -$175 M -30.2% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 -$716 M -$176 M -32.7% Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$654 M -$167 M -34.4% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 -$601 M -$120 M -24.9% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 -$579 M -$130 M -29% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 -$539 M -$114 M -26.9% Dec 31, 2012 10-K 2014-02-26
Q3 2012 -$486 M -$88.1 M -22.1% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 -$481 M -$100 M -26.4% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 -$449 M -$73.4 M -19.6% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 -$425 M -$53.8 M -14.5% Dec 31, 2011 10-K 2013-02-26
Q3 2011 -$398 M -$39.3 M -10.9% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 -$381 M +$196 M +34% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 -$376 M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 -$371 M Dec 31, 2010 10-K 2012-02-22
Q3 2010 -$359 M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 -$576 M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.